SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-09-003634
Filing Date
2009-10-01
Accepted
2009-10-01 17:14:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 KERYX BIOPHARMACEUTICALS, INC. p09-1841sc13g.txt SC 13G 20669
  Complete submission text file 0000902664-09-003634.txt   22525
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Subject) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78786 | Film No.: 091099475
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 BROADWAY, SUITE 1019 NEW YORK NY 10271
Business Address 120 BROADWAY, SUITE 1019 NEW YORK NY 10271 212-608-3300
Empery Asset Management, LP (Filed by) CIK: 0001469336 (see all company filings)

IRS No.: 262107121 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G